Bacteremic pneumococcal infections in immunocompromised patients without AIDS: the impact of β-lactam resistance on mortality
Manuel L. Fernández Guerrero(Hospital Universitario Fundación Jiménez Díaz), Miguel Górgolas(Hospital Universitario Fundación Jiménez Díaz), Jorge A. Marrero(University of Pennsylvania), José Manuel Ramos(Universitat de Miguel Hernández d'Elx), Ricardo Fernández Roblas(Hospital Universitario Fundación Jiménez Díaz), Manuel Cuenca(Hospital Universitario Fundación Jiménez Díaz)
Cited by 31
Related Papers
AASLD guidelines for the treatment of hepatocellular carcinoma
|Hepatology|2017|4.1k
Hepatobiliary Cancers
|Journal of the National Comprehensive Cancer Network|2009|2.3k
Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma: Subanalyses of a phase III trial
|Journal of Hepatology|2012|821
Comparison of imputation methods for missing laboratory data in medicine
|BMJ Open|2013|511
Observational registry of sorafenib use in clinical practice across Child-Pugh subgroups: The GIDEON study
|Journal of Hepatology|2016|385